We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
+15.51%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$21.7B
AUM Growth
+$4.07B
(+23%)
Cap. Flow
+$1.67B
Cap. Flow
% of AUM
7.73%
Top 10 Holdings %
Top 10 Hldgs %
19.87%
Holding
879
New
62
Increased
394
Reduced
319
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$102M |
| 2 |
Alibaba
BABA
|
+$93.1M |
| 3 |
Salesforce
CRM
|
+$85.2M |
| 4 |
Ciena
CIEN
|
+$83.9M |
| 5 |
Amazon
AMZN
|
+$77.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Global Payments
GPN
|
+$42.2M |
| 2 |
Plug Power
PLUG
|
+$40.5M |
| 3 |
First Solar
FSLR
|
+$36.9M |
| 4 |
Elevance Health
ELV
|
+$34.7M |
| 5 |
Trimble
TRMB
|
+$33.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.71% |
| 2 | Consumer Discretionary | 16.94% |
| 3 | Healthcare | 15.57% |
| 4 | Financials | 8.2% |
| 5 | Communication Services | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Boston Scientific
BSX
$73.5B
| $26.8M | 0.12% |
745,263
-309,011
| -29% | -$11.1M |
|
202
Sarepta Therapeutics
SRPT
$1.79B
| $26.7M | 0.12% |
156,433
+18,915
| +14% | +$2.8M |
|
203
KeyCorp
KEY
$24.3B
| $26.2M | 0.12% |
1,597,722
+171,522
| +12% | +$2.5M |
|
204
VEON
VEON
$3.92B
| $26M | 0.12% |
689,194
-191,920
| -22% | -$6.83M |
|
205
EPAM Systems
EPAM
$5.06B
| $25.9M | 0.12% |
72,309
+2,527
| +4% | +$843K |
|
206
GDS Holdings
GDS
$6.28B
| $25.9M | 0.12% |
276,132
+162,259
| +142% | +$14.4M |
|
|
FSR
207
DELISTED
Fisker Inc.
FSR
| $25.8M | 0.12% |
1,758,850
+1,379,159
| +363% | +$20.3M |
|
208
Dollar General
DG
$27.2B
| $25.7M | 0.12% |
122,119
-75,638
| -38% | -$16.2M |
|
209
Progressive
PGR
$124B
| $25.5M | 0.12% |
258,189
+31,500
| +14% | +$2.98M |
|
210
Qualcomm
QCOM
$172B
| $25.1M | 0.12% |
164,847
+8,216
| +5% | +$1.14M |
|
211
Mettler-Toledo International
MTD
$28.8B
| $25.1M | 0.12% |
22,024
+1,432
| +7% | +$1.57M |
|
|
XLRN
212
DELISTED
Acceleron Pharma
XLRN
| $24.9M | 0.12% |
194,897
+81,205
| +71% | +$9.52M |
|
213
Neurocrine Biosciences
NBIX
$16.7B
| $24.7M | 0.11% |
258,029
-5,867
| -2% | -$567K |
|
214
Waste Management
WM
$90.3B
| $24.7M | 0.11% |
209,293
-90,768
| -30% | -$10.6M |
|
215
Orion Energy Systems
OESX
$78.8M
| $24.5M | 0.11% |
248,676
+136,417
| +122% | +$11.8M |
|
216
ASML
ASML
$673B
| $24.5M | 0.11% |
50,183
+868
| +2% | +$365K |
|
217
Rockwell Automation
ROK
$48.6B
| $24.4M | 0.11% |
97,194
-1,412
| -1% | -$345K |
|
218
Mastercard
MA
$491B
| $24.1M | 0.11% |
67,625
-17,539
| -21% | -$5.83M |
|
219
CVS Health
CVS
$122B
| $24.1M | 0.11% |
352,709
-28,460
| -7% | -$1.85M |
|
220
Ball Corp
BALL
$16.5B
| $23.7M | 0.11% |
254,731
+18,874
| +8% | +$1.74M |
|
221
Expeditors International
EXPD
$23.4B
| $23.7M | 0.11% |
249,060
-9,523
| -4% | -$867K |
|
222
Idexx Laboratories
IDXX
$47.3B
| $23.6M | 0.11% |
47,177
+6,835
| +17% | +$3.06M |
|
|
ARNA
223
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $23.3M | 0.11% |
302,816
+33,247
| +12% | +$2.49M |
|
224
UDR
UDR
$12.1B
| $23.2M | 0.11% |
604,638
+475,223
| +367% | +$17.3M |
|
225
ConocoPhillips
COP
$147B
| $22.6M | 0.1% |
564,529
+59,604
| +12% | +$2.2M |
|
Similar funds
BNP Paribas Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, BNP Paribas Asset Management held 879 positions worth $21.7B, up 23% from $17.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Asset Management deployed $1.67B of net new capital in Q4 2020, opening 62 new positions and adding to 394 existing holdings. Its largest new stake was Array Technologies: 1,359,474 shares worth $58.6M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Global Payments, an estimated $42.2M trimmed.
- BNP Paribas Asset Management's largest Q4 2020 buy was Array Technologies: 1,359,474 shares worth $58.6M.
- BNP Paribas Asset Management added most to Microsoft in Q4 2020, an estimated $102M increase.
- BNP Paribas Asset Management's biggest Q4 2020 reduction was Global Payments, cutting an estimated $42.2M.
- BNP Paribas Asset Management fully exited Dunkin' Brands Group, Inc. in Q4 2020, selling an estimated $23.9M.
- BNP Paribas Asset Management's ten largest holdings make up 20% of its $21.7B portfolio in Q4 2020.
- BNP Paribas Asset Management opened 62 new positions and closed 44 in Q4 2020.
- BNP Paribas Asset Management's portfolio value rose 23% quarter-over-quarter to $21.7B.
Based on BNP Paribas Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.